Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer
Authors
James, Nicholas D.Spears, Melissa R.
Clarke, Noel W.
Dearnaley, David P.
Mason, Malcolm D.
Parker, Christopher C.
Ritchie, Alastair W. S.
Russell, J. Martin
Schiavone, Francesca
Attard, Gerhardt
de Bono, Johann S.
Birtle, Alison
Engeler, Daniel S.
Elliott, Tony
Matheson, David
O’Sullivan, Joe
Pudney, Delia
Srihari, Narayanan
Wallace, Jan
Barber, Jim
Syndikus, Isabel
Parmar, Mahesh K. B.
Sydes, Matthew R.
Issue Date
2016-11-25
Metadata
Show full item recordCitation
Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer 2016, 2 (3):348 JAMA OncologyPublisher
American Medical AssociationJournal
JAMA OncologyType
Journal articleLanguage
enISSN
2374-2437Sponsors
The Medical Research Council sponsored the study and was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Funding was also provided by Cancer Research UK, Astellas, Janssen, Novartis, Sanofi-Aventis, and Pfizer, none of which were directly involved in the research.ae974a485f413a2113503eed53cd6c53
10.1001/jamaoncol.2015.4350